Literature DB >> 14977346

Xenon modulates neutrophil adhesion molecule expression in vitro.

L W de Rossi1, N A Horn, A Stevanovic, W Buhre, G Hutschenreuter, R Rossaint.   

Abstract

BACKGROUND AND
OBJECTIVE: Xenon reduces the infarct size after regional ischaemia in the rabbit heart in vivo, but the underlying mechanisms are unknown. Since adhesion molecules on neutrophils are closely involved in the pathophysiology of ischaemia/reperfusion injury and modulation of neutrophil function, we investigated the effect of xenon on neutrophil adhesion molecule expression in vitro.
METHODS: Freshly isolated neutrophils were incubated with 30% or 60% xenon for 60 min. In unstimulated and after stimulation with either N-formyl-methionyl-leucyl-phenylalanine or phorbol-12-myristate-13-acetate neutrophil surface expression of PSGL-1, L-selectin, CD11a and CD11b were measured by flow cytometry.
RESULTS: At both concentrations, xenon reduced the surface expression of PSGL-1 by 10% (P < 0.05), and of L-selectin by 15% (P < 0.05) in the 60% xenon group. Furthermore, N-formyl-methionyl-leucyl-phenylalanine activated neutrophils showed an increased removal of L-selectin from the neutrophil surface following incubation with xenon (30% compared to controls, P < 0.05). Neutrophil beta2-integrin expression was not altered by xenon.
CONCLUSIONS: Xenon increases the removal of the selectins PSGL-1 and L-selectin from the neutrophil surface in vitro. Since both selectins are involved in the initial contact between neutrophils and endothelial cells, xenon may affect neutrophil adhesion to endothelium during ischaemia/reperfusion injury. However, because the beta2-integrin expression was unaffected by xenon, further investigations are required to clarify whether xenon may modulate neutrophil transmigration through endothelial cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977346     DOI: 10.1017/s0265021504002108

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  5 in total

1.  Mechanisms of xenon- and isoflurane-induced preconditioning - a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway.

Authors:  Nina C Weber; Octavian Toma; Jessica I Wolter; Nicole M Wirthle; Wolfgang Schlack; Benedikt Preckel
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.

Authors:  Nina C Weber; Octavian Toma; Jessica I Wolter; Detlef Obal; Jost Müllenheim; Benedikt Preckel; Wolfgang Schlack
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

3.  Application of medical gases in the field of neurobiology.

Authors:  Wenwu Liu; Nikan Khatibi; Aishwarya Sridharan; John H Zhang
Journal:  Med Gas Res       Date:  2011-06-27

4.  Xenon triggers pro-inflammatory effects and suppresses the anti-inflammatory response compared to sevoflurane in patients undergoing cardiac surgery.

Authors:  Thomas Breuer; Christoph Emontzpohl; Mark Coburn; Carina Benstoem; Rolf Rossaint; Gernot Marx; Gereon Schälte; Juergen Bernhagen; Christian S Bruells; Andreas Goetzenich; Christian Stoppe
Journal:  Crit Care       Date:  2015-10-15       Impact factor: 9.097

5.  Delayed xenon post-conditioning mitigates spinal cord ischemia/reperfusion injury in rabbits by regulating microglial activation and inflammatory factors.

Authors:  Yan-Wei Yang; Yun-Lu Wang; Jia-Kai Lu; Lei Tian; Mu Jin; Wei-Ping Cheng
Journal:  Neural Regen Res       Date:  2018-03       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.